Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2/3 1Phase 2 1

Status

Not yet recruiting 4Completed 4Unknown 2Terminated 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1Breast 1

Conditions

Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Sarcoma 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Lung Neoplasms 3Esophageal Squamous Cell Carcinoma 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Carcinoma, Hepatocellular 2Advanced Solid Tumors 2Advanced Endometrial Cancer 2Advanced Breast Cancer 2Thrombosis 1Thrombophilia 1Solid Tumors 1Small Cell Lung Carcinoma 1Resectable Esophageal Squamous Cell Carcinoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Non-Muscle Invasive Bladder Neoplasms 1Neuroma 1Neoplasms 1

Interventions

Bevacizumab 37Oxaliplatin 17Capecitabine 17Irinotecan 15Leucovorin 13HMPL-013 12Fluorouracil 12Cetuximab 11trifluridine tipiracil drug combination 7irinotecan sucrosofate 6tipiracil 5Trifluridine 5Specimen Handling 5Drug Therapy 5tislelizumab 4Standard of Care 4Mitomycin 4Magnetic Resonance Spectroscopy 4Injections 4Folfox protocol 4trametinib 3toripalimab 3pembrolizumab 3Nivolumab 3IFL protocol 3Colonoscopy 3Blood Specimen Collection 3Biopsy 3sotorasib 2sintilimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Colorectal Neoplasms × Injections × Clear all
NCT07621497 2026-06-02

FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)

Sun Yat-sen University

Phase 2 Not yet recruiting
229 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07321847 2026-01-07

INJECTABL-3

Immunophotonics, Inc.

Phase 2/3 Not yet recruiting
717 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06948539 2025-04-29

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Not yet recruiting
66 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms

NCT06710561 2024-12-03

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Injectable SPN01 in Phase I.

Beijing SonoPhotoNano Medical Technology Co., Ltd.

Phase 1 Not yet recruiting
32 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡